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Abstract
Chronic infectious diseases, such as Helicobacter pylori, can promote cancer in a large part through
induction of chronic inflammation. Oncogenic K-Ras mutation in epithelial cells activates
inflammatory pathways, which could compensate for a lack of infectious stimulus. Gastric
histopathology and putative progenitor markers (Dcamkl1, Keratin 19) in Keratin 19-K-Ras-V12
(K19-kras) transgenic mice were assessed at 3, 6, 12 and 18 months of age, in comparison with
Helicobacter felis (H. felis)-infected wild-type littermates. Inflammation was evaluated by RT-PCR
of pro-inflammatory cytokines, and K19-kras mice were transplanted with GFP-labeled bone
marrow. Both H. felis infection and kras mutation induced upregulation of pro-inflammatory
cytokines, expansion of Dcamkl1+ cells, and progression to oxyntic atrophy, metaplasia, hyperplasia
and high-grade dysplasia. K19-kras transgenic mice uniquely displayed mucous metaplasia as early
as 3 months, and progressed to high-grade dysplasia and invasive intramucosal carcinoma by 20
months. In bone marrow transplanted K19-kras mice that progressed to dysplasia, a large proportion
of stromal cells were GFP+ and bone marrow-derived, but only rare GFP+ epithelial cells were
observed. GFP+ BMDCs included leukocytes and CD45− stromal cells that expressed vimentin or
αSMA and were often found surrounding clusters of Dcamkl1+ cells at the base of gastric glands. In
conclusions, the expression of mutant Kras in K19+ gastric epithelial cells can induce chronic
inflammation and promote the development of dysplasia.
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Introduction
Helicobacter-related gastric cancer arises through a multistage progressiion that involves the
conversion of normal gastric epithelium to regions of hyperplasia, dysplasia and finally,
invasive adenocarcinoma. This multistep process is associated with the accumulation of genetic
and/or epigenetic alterations in the target cell population that leads to their malignant
transformation. Helicobacter infection contributes to the pathogenesis of gastric cancer in a
large part through the induction of chronic inflammation (1,2), which can induce proliferation
and thus opportunity for mitotic error. In addition, Helicobacter infection can promote the
development of cancer through mobilization and recruitment of bone marrow-derived cells
(BMDCs) that contribute to cancer development in diverse ways (3-5).
However, while chronic inflammation can likely initiate and promote oncogenic mutation and
transformation, accumulating data suggests that in many cases the converse is also true, and
that oncogenic mutations can also lead to the development of chronic inflammation (6).
Cytokines and soluble mediators produced by oncogene mutations in cancer cells recruit and
activate inflammatory cells to develop a tumor microenvironment, which further stimulate
tumor progression (6,7).
One oncogene that has been strongly linked to the development of chronic inflammation has
been the Ras oncogene (8). Expression of a mutant K-ras oncogene induces strong immune
responses through activation of cytokines and T cells (9-11). In transgenic mice modeling
pancreatic cancer, based in part on K-ras mutations in PDX1+ cells, significant inflammatory
and stromal responses correlate with cancer progression (12). Expression of the mutant K-ras-
V12 oncogene in cyokeratin-19 (K19)-expressing pancreatic cells also results in pancreatic
ductal hyperplasia with lymphocytic infiltration (13). Studies from Bar-Sagi et. al. showed
that many of the key downstream targets of K-ras were chemokines and cytokines (10,14).
Further studies demonstrated that transformed cell survival and tumor progression are
dependent on these induced cytokines (15).
In a previous report, K-ras-V12 was expressed in the gastric epithelium using the K19
promoter, and resulted in mucous metaplasia and parietal cell loss (13). However, a detailed
investigation the inflammatory responses and development of dysplasia in this model has not
yet been reported. K19 is a member of the family of intermediate filaments that is highly
expressed in the proliferative zone of the gastrointestinal tract (13,16-18). In the stomach, K19
is expressed in the neck/isthmus region of the glandular unit, in the same area where stem/
progenitor cells reside (13,16). In theory, induction of cancer is most likely to occur when
oncogenic mutations accumulate in long-lived stem or progenitor cells. While an authentic
stem or progenitor cell for the oxyntic glands of the stomach as not yet been identified, one
candidate progenitor marker that has emerged is Doublecortin and calcium/calmodulin-
dependent protein kinase-like-1 (Dcamkl1), a gene shown to be upregulated in an enriched
gastric epithelial progenitor cell population from the murine fundus (19). Dcamkl1+ cells reside
in the neck/isthmus region of the stomach glands and do not express biomarkers associated
with differentiated lineages (19,20).
The aim of the current study was to compare the effects of mutant K-ras expression to chronic
H. felis infection on the gastric epithelium. We show that mutant K-ras can substitute for
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Helicobacter infection in the induction of chronic inflammation, leading to expansion of
putative gastric progenitors and induction of gastric intraepithelial neoplasia (GIN).
Materials and Methods
Mice
The K19-K-ras-V12 (K19-kras) transgenic mice were generated previously (13), using a 2.1-
kb genomic fragment of the 5 flanking region/promoter of the mouse K19 gene linked to the
full-length mutant human K-ras (Val 12) gene. K19-K-ras-V12 transgenic mice were
backcrossed to C57/BL6 mice for at least 3 generations under the Columbia University IACUC.
Chicken beta-actin EGFP transgenic mice (8-10 weeks old) were purchased from Jackson
Laboratories (Bar Harbor, ME).
H. felis infection, histopathology and immunocytochemistry
H. felis infection was carried out by gavage as previously described with H. felis (ATCC 49179)
(4). Stomachs were fixed in 10% neutral buffered formaldehyde and routine hematoxylin and
eosin (H&E) sections were reviewed by board-certified veterinary pathologists and graded
according to previously described criteria (21,22). Immunohistochemistry was performed on
4μm sections with avidin biotin-peroxidase complex kits (Vector Laboratories, Burlingame,
CA) and counterstained with Mayer’s hematoxylin. For primary antibodies, mouse anti-
Hydrogen/Potassium ATPase (H/K-ATPase) beta (Affinity BioReagents, Golden, CO), rabbit
anti-Ki67 (Abcam), rabbit anti-Cytokeratin 19 (Abcam), rabbit anti-Dcamkl1 (Abagent), rabbit
anti-mouse-TFF2 (established in our laboratory), rabbit anti-TFF1 (Abcam) and mouse anti-
Muc5AC (Abcam) or rabbit anti-GFP (Invitrogen) were used.
PCR and qRT-PCR analysis
Real-time PCR reactions with QuantiTect SYBR green PCR kit (QIAGEN, Maryland, MA)
and primers (Suppl. Table 1) were run on an ABI Prism 7300 (Applied Biosystems,
Branchburg, NJ). mRNA quantities were analyzed in duplicate and normalized against
GAPDH as an internal control. Results are expressed as relative gene expression using the
ΔΔCt method.
Bone marrow transplantation
Bone marrow transplantation was carried out as previously described with 5 million cells/
animal (3). Mice were euthanized at 3, 6, and 12 months post-transplantation.
Flow cytometry and MSC culture
Freshly isolated bone marrow cells were processed for flow as previously described (4,6) and
after incubiation with PE-conjugated anti mouse CD45 antibody (BD Pharmingen, San Diego,
CA) or PE-conjugated rat IgG2a antibody (isotype control) Jackson ImmunoResearch, West
Grove, PA) and DAPI, were analyzed using BD LSRII (Becton, Dickinson). Mesenchymal
stem cells were cultured as previously described (23).
Y chromosome and Keratin 19 in situ hybridization
In situ hybridization for Y-chromosome or K19 were performed using a Texas Red-labeled Y-
chromosome paint (Star-FISH; Cambio, Cambridge, UK) or a DIG-labeled antisense riboprobe
(Roche) following manufactuer’s protocols, as previously described (24).
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Immunofluorescence
Immunofluorescence was performed following in vitro fixation-perfusion with 4%
paraformaldehyde followed by freezing and embedding in OCT and frozen.4μm sections were
prepared and blocked with 1% FBS in PBS for 1 hour at room temperature, then rat anti-E-
cadherin antibody (Zymed, South San Francisco, CA), rat anti-CD45 (eBioscience), rabbit anti-
αSMA (Abcam), rabbit anti-cytokeratin 19 (Abcam), rabbit anti-Dcamkl1 (Abagent), mouse
anti-vimentin (Abcam), diluted in PBS with 1% FBS (1:100 dilution) were applied. Following
overnight incubation at 4°C, Texas Red conjugated anti-rat, rabbit or mouse IgG antibodies
(Jackson ImmunoResearch) were applied, respectively, with 1% FBS in PBS (1: 300 dilution)
and incubated for 1 hour at room temperature. Nuclei were stained with DAPI, and mounted
using Vectashield (Vector Laboratories) for microscopy.
Statistical Analysis
Statistical analysis was performed using t test and p values <0.05 were considered significant.
Data are expressed as mean ± SEM.
Results
K19-kras mice developed gastric hyperplasia and histologic inflammation
To assess the effects that the 2.1kb K19 promoter-driven mutant K-ras-V12 oncogene has on
the induction of chronic inflammation, we first investigated the gross appearance, gastric
histopathology, and inflammatory responses in K19-kras transgenic mice in comparison to H.
felis-infected wild type (WT) mice over time. Colonization of H. felis in pyloric and fundic
glands of WT mice was confirmed by examination of H&E-stained sections and PCR
amplification of H. felis-specific DNA sequence (Figure S1). Wet stomach weight and the ratio
of wet stomach weight to body weight of K19-kras mice were significantly higher than those
of control mice, regardless of H. felis infection (Figure 1A). This was consistent with the gross
appearance of the stomach, where severe mucosal thickness and enlarged folds was
consistently observed in K19-kras mice (Figure 1B).
Histopathologic scoring of H&E-stained gastric tissue sections from mice in each group using
previously published criteria (21,22) showed that H. felis-infected WT mice exhibited much
greater chronic active gastritis, oxyntic atrophy, intestinal metaplasia, hyperplasia, and
dysplasia that progressed over time (Figure 1C), consistent with the multistage model of
Helicobacter-related gastric carcinogenesis (22). Inflammation scores in K19-kras mice were
similar to that of WT mice with H. felis infection. K19-kras mice also developed oxyntic
atrophy, pseudopyloric metaplasia, hyperplasia, and dysplasia by 3 months, and the lesions
persisted until the end of the study (Figure 1D). Mucous metaplasia, characterized by
replacement of parietal cells with foamy Alcian blue-staining H/K-ATPase− cells without
glandular dysplasia, was observed in the oxyntic mucosa of K19-Kras mice, but not in wild
type mice, even with H. felis infection (Figure 1C), consistent with previous reports (13,22).
The K19-kras mice also showed a marked lymphocytic infiltrate with hyperplastic lymphoid
follicles, similar in appearance and frequency to those found in H. felis-infected WT mice
(Figure S2A). These results demonstrate that K-ras mutation in epithelial cells is sufficient to
induce chronic inflammatory responses in the gastric epithelium.
Oncogenic K-ras mutation in gastric epithelial cells upregulates cytokine and chemokine
expression
The finding of chronic inflammation in K19-kras mice suggested that K-ras mutation in gastric
epithelial cells triggered the activation of specific immune responses that may be similar to H.
felis-related chronic gastritis. RT-PCR analysis of mice 6-12 months of age revealed increased
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gastric mRNA expression of IL-6 and IL-1β in both H. felis infected WT and K19-kras mice,
compared to WT uninfected controls (Figure 2A). Additionally, CXCL1 was upregulated in
both these groups, while the expression of CXCL5 was up regulated only in K19-kras mice
(Figure 2B). Interestingly, CXCL1 and IL-6 expression retained the highest degree of
correlation with dysplasia scores in K19-kras mice (Figure 2C). Similar trends were observed
for IL-1β and CXCL5, albeit with smaller R2 values. There were no differences among the
three cohorts in the expression of other detected cytokines and chemokines, including IFNγ,
TNFα, CCL2, CCL3, and CXCL2 (data not shown). In younger (3 month) mice, expansion of
pit cells was moderate (Figure S2B). Consequently, at this point, the aforementioned
inflammatory cytokines were minimally elevated, while the chemokine CXCL1 was
significantly upregulated (Figure S2B), supporting an important role for CXCL1 in phenotype
development. Although Kras is known to induce COX-2 expression which can drive
tumorigenesis (25), we were unable to detect any upregulation of COX-2 expression in younger
mice (≤ 12 months); in contrast, expression was nearly 3-fold higher in K19kras over WT mice
over 12 months of age, correlating with progression to dysplasia (Figure S3).
Expression of growth factors HB-EGF and amphiregulin was significantly upregulated in the
stomachs of K19-kras mice when compared to WT mice, regardless of H. felis infection (Figure
2D). These results suggest that progression of gastric pre-neoplastic lesions in K19-kras mice
occurs in the setting an inflammatory environment similar to that found in H. felis-dependent
chronic gastritis, characterized by expression of CXCL1, IL-1β, and IL-6. However, the unique
phenotype of the K19-kras mouse is associated with expression of additional inflammatory
chemokines and growth factors that are relatively specific to the K-ras-V12 mutation, which
include CXCL5, HB-EGF, and amphiregulin.
Dcamkl1+ putative tissue stem/progenitor cells are expanded in the preneoplastic gastric
lesions of K19-kras mice
The progression to metaplasia and dysplasia in the stomachs of K19-kras mice was associated
with changes in epithelial differentiation and proliferation. In the stomach of normal WT mice,
K19 staining was observed primarily in pit cells which comprised the upper one sixth of the
gastric glands (Figure 3A). Ki67+ proliferating cells reside in the isthmus and upper neck region
(Figure 3C), in close proximity to rare Dcamkl1+ cells found in this region (Figure 3D).
Throughout and below the neck region are H/K-ATPase+ parietal cells, which make up the
majority of glands (Figure 3B).
The gastric epithelium of K19-kras mice at 12 months of age displayed obvious parietal cells
loss, with only a small number of H/K-ATPase+ cells remaining at the base of the gastric glands
(Figure 3F). Excluding these rare parietal cells, a majority of the remaining cells were mucus-
producing K19+ pit cells (Figure 3E), which had expanded to comprise nearly 2/3rds of the
entire gland, consistent with previous reports (13). Expression of TFF1 and Muc5AC in the
K19-Kras mouse stomach indicated that the majority of K19+ cells in the upper middle region
of glands were expanded surface pit cells (Figure S4A,B). Ki67+ proliferating cells shifted
over time from the neck region to the bottom of gastric glands, slightly above the remaining
parietal cells. Interestingly, the number of Dcamkl1+ cells increased markedly to many cells
in each glandular unit, located just below the proliferative zone and just above the residual
parietal cells (Figure 3G, H). It should be noted that Dcamkl1 is strictly a putative progenitor
marker based on its homeostatic location and frequency throughout the gastric epithelium. Lgr5
can give rise to gastric antral glands in the murine adult, but Lgr5 is not expressed in the adult
gastric corpus (26). We confirmed that Lgr5-EGFP is expressed at the base of gastric antral
glands, while Dcamkl1+ cells reside slightly above, never co-localizing (Figure S4C).
Therefore, these results suggest that the Dcamkl1+ putative epithelial progenitor pool expands
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independent of Lgr5 expression, under inflammatory responses induced by mutant K-ras
expression.
K19-K-ras-V12 mice develop high grade dysplasia by 20 months of age
We followed a cohort of aged mice, combining data from mice that survived 16 to 21 months
of age, to investigate possible progression of the gastric preneoplastic lesions. As expected,
K19-kras mice and H. felis-infected WT mice continued to exhibit higher inflammation scores
when compared to WT mice without H. felis infection, becoming progressively more severe
with longer observation periods (Figure S5, see also Figure 1D). Histology scores for dysplasia
were also elevated after long-term observation, in parallel with the severity of inflammation
(Figure 4A, see also Figure 1D). Among these mice, 3 of 4 (75.0%) H. felis-infected wild type
mice and 3 of 8 (37.5%) K19-kras mice developed gross papillary tumors in the stomach
(Figure 4B). The lesions of three K19-kras mice were histologically defined as high-grade
dysplasia or intramucosal carcinoma, with some areas invading into sub-mucosal layers (Figure
4C).
Immunohistochemistry on serial tissue sections revealed that the lower portions of dysplastic
glands contained a mixture of TFF2+ and Dcamkl1+ cells (outlined in red in Figure 4D, and
Figure S6B,C, S7B,D). More apical regions of these glands typically contained strongly-
staining K19+ cells, consistent with a surface epithelial phenotype (Figure S6A, S7C). Keratin
19 expression was especially strong in glands with squamous metaplasia (Fig. S6A, lower
right). Infrequently, weakly-staining K19+ regions also contained expanded Dcamkl1+ cells
(outlined in black with arrowheads, and as magnified insets, Figure 4D, and arrowheads in
Figure S7A, B). However, TFF2 and K19 expression were clearly distinct from Dcamkl1, and
colocalization of these markers was never observed in these serial sections or double
immunofluorescence (Figure S7E). It appears that keratin 19 mRNA is expressed early on as
the pit cell migrates upward through the gland, and prior to keratin 19 protein expression.
Therefore, it is likely that K-ras is expressed in a few cells that are not reactive to the K19
antibody. While the transgene-derived mutant human K-ras could not be directly detected due
to high homology with murine K-ras, we observed that K19 mRNA expression as assessed by
in situ hybridization is present a few cells below kertatin 19 protein+ cells, above the region
where Dcamkl1 is typically expressed (Figures S7F).
Similar immunohistochemical observations were made in regions of high-grade dysplasia,
where Dcamkl1+ cells were expanded but never coexpressed TFF2 or K19 (arrows in Figure
4D). Proliferating Ki67+ cells typically resided between the aforementioned cell types,
although they were occasionally found to be TFF2+ (Figure 4D). Although we cannot
completely exclude the possibility that the observed expansion of Dcamkl1+ cells is due to
expression of K-ras in these cells, the lack of colocalization with K19 mRNA and protein would
suggest that it is more likely due to alterations in paracrine signals and/or their niche.
K19-kras transgenic mice display recruitment of BMDCs to the tumor microenvironment
To investigate the role of mutated K-ras in the recruitment of bone marrow derived cells
(BMDCs) to the tumor microenvironment, we performed bone marrow transplantation (BMT)
studies. Bone marrow from donor chicken beta actin-EGFP mice (WT/GFP) was transplanted
into K19-kras or uninfected WT recipients. Six months after BMT, half of the bone marrow
cells from recipient mice expressed GFP, similar to donor mice, with most of the GFP+ cells
CD45+ hematopoietic cells (Figure S8A). Successful engraftment was confirmed by
demonstration of GRP expression by mesenchymal stem cell cultures (Figure S8B),
quantitative detection of transgene DNA sequences in BMT recipient bone marrow (Figure
S8C), and detection of GFP+ cells in MSC cultures established from peripheral blood of all
BMT recipient K19-kras mice (Figure S8B). Twelve to 18 months after BMT, gastric tissues
Okumura et al. Page 6
Cancer Res. Author manuscript; available in PMC 2011 November 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
from K19-kras BMT recipient mice displayed all the phenotypic changes of non-transplanted
K19-kras mice, including mucosal thickness, histological pathologies, shift of the Ki67+
proliferation zone, and dramatic expansion of Dcamkl1+ cells (Figure S8B, D).
In the BMT recipient mice, only rare GFP+ cells were observed in the gastric mucosa of
uninfected WT mice, while K19-kras mice had a greater than 10-fold increase in the number
of recruited cells (Figure 5A-C). E-cadherin, an epithelial-specific cell surface molecule, was
detected in all epithelial cells of the gastric epithelium, including dysplastic glands. More
detailed analysis of the glandular areas with confocal microscopy revealed that, although a
small number of GFP+ cells were E-cadherin(+) epithelial cells, a majority were E-cadherin
(−) stromal cells (Figure 5D).
The expression of GFP was confirmed by immunohistochemically staining for GFP (Figure
5E). In addition, since GFP was present in only half of bone marrow cells (Figure S8A), we
performed Y-chromosome in situ hybridization (Y-FISH) on sections prepared from female
recipients that had received male donor bone marrow. Gastric sections showed many Y-
chromosome+ cells in lymphoid follicles (Figure S8E) but no Y chromosome (+) cells in the
gastric glands (Figure 5F). These findings suggest that the K19-expressing dysplastic gastric
epithelium does not derive from the engrafted BMDCs.
To further characterize the GFP+ BMDCs, we performed immunofluorescent staining against
CD45, vimentin, and alpha smooth muscle actin (αSMA). In all gastric sections, we detected
colocalization of GFP with CD45, or spindloid cells positive for vimentin, and/or αSMA,
indicating the BMDCs had differentiated primarily into leukocytes, fibroblasts, and
myofibroblasts, (Figure 6A). By 12 months, an estimated 15% of the recruited GFP+ BMDC
in the grastric epithelium of WT mice with H. felis and K19kras mice were myofibroblasts, as
characterized by their morphologic appearance and co-expression of αSMA (Figure S9).
To further understand the expansion of Dcamkl1+ cells, we performed staining against GFP,
αSMA and F4/80 in K19-kras BMT recipient mice. A plethora of GFP+ cells were found
surrounding most clusters of Dcamkl1+ cells. Excessive alpha-SMA+ stromal cells, as well as
inflammatory F4/80+ macrophages, were typically seen surrounding these clusters, indicating
that K-ras expression in adjacent putative progenitor cells favored an altered, inflammatory
microenvironment (Figure 6B).
Discussion
In this study, we demonstrate that oncogenic K-Ras mutation in K19-expressing putative
gastric epithelial progenitor cells activates inflammatory pathways and induces gastric atrophy,
metaplasia, and dysplasia in a manner that largely parallels H. felis-induced carcinogenesis.
K-ras-dependent chronic inflammation leads to recruitment of BMDCs that contribute
primarily to the stromal microenvironment, and correlates with expansion of Dcamkl1+
putative progenitor cells and development of high-grade dysplasia and rarely intramucosal
carcinoma. Interestingly, H. felis infection of K19-Kras mice did not accelerate gastric cancer
progression in these mice (data not shown), suggesting that the two models (K-ras mutation
and H. felis infection) may progress through overlapping and/or non-additive pathways. Taken
together, K-ras mutation is able to compensate for a lack of infectious stimulus, such as H.
felis infection, to induce inflammation and carcinogenesis.
The development of dysplasia in the K19-kras mouse was not entirely surprising, given the
known role of K-ras as an oncogene for the pancreas and other organs in the mouse (11,12,
27), and the fact that K-ras mutations have been reported rarely in gastric cancer (28,29).
Although previous reports have noted only gastric hyperplasia and mucous metaplasia in K19-
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kras mice up to 18 months of age (13), the current study is the first to examine the phenotype
in a pure inbred (C57BL/6) background.
Previous studies by our group have modeled gastric cancer in mice using chronic
Helicobacter infection or transgenic overexpression of cytokines that can drive gastric
carcinogenesis independent of Helicobacter infection (4). Indeed, many cancers arise in the
setting of chronic inflammation, which likely plays a role in both the initiation and promotion
of tumors (30) and can lead to oncogenic mutations by inducing proliferation and increasing
the mutation rate (31). However, cancers are also thought to arise in the absence of chronic
inflammation through spontaneous or carcinogen-induced mutations in key oncogenes and
tumor suppressor genes, with inflammation developing later on (32). In this latter model,
transformed cells produce inflammatory mediators that attract tumor promoting inflammatory
cells and set up cytokine networks. Accordingly, a number of studies have also shown that
specific oncogenic mutations lead to a chronic inflammatory state (6,7).
Oncogenic Kras mutation in epithelial cells induces a number of molecular pathways that
intrinsically regulate cellular processes such as proliferation, survival, and migration, that
contribute to tumorigenesis (1,12,33). However, another consequence of oncogenic Ras
signaling in carcinogenesis is the upregulation of cytokines and chemokines (9-11). Indeed,
most of the cytokine/chemokines elevated in K19-kras mouse in this study have been reported
to promote tumor development (4,10,34,35). The development of chronic inflammation in the
stomachs of K19-kras transgenic mice was associated with significant increases in CXCL1,
IL-1β, and IL-6. It has previously been reported that oncogenic Ras mutations are able to induce
the secretion of IL-6, which acts in a paracrine and autocrine fashion to promote tumor growth
(34). K-ras has also been shown to upregulate the expression of IL-1β in epithelial cells,
propagating and enhancing inflammatory networks (36). The chemokine CXCL1 is over-
expressed in human gastric cancers (37), and is a known critical downstream mediator of
mutant Ras that recruits neutrophils (38), supports angiogenesis (39), regulates the
microenvironment (35), and directly promotes tumorigenesis (39). Moreover, CXCL1 (also
known as Gro1) is associated with other epithelial cancers such as hepatocellular carcinoma,
even in the absence of overt neutrophil recruitment (40). The induction of dysplasia by K-ras
correlated most tightly in our study with increased CXCL1, but further studies will be required
to understand the role of CXCL1 in gastric cancer progression.
K-ras is known to induce COX-2 expression largely through upregulation of COX-2 mRNA
stability (41), and the phenotype of K19-kras mice shows striking similarities to mice that
overexpress COX-2-derived prostaglandins in K19+ cells (25); notably, both K19-kras mice
and K19-C2mE mice exhibit expansion of mucous-producing cells and eventual gastric tumor
development. While we were unable to detect increased COX-2 expression before the
development of moderate dysplasia, it is interesting to speculate that it may have a role in
phenotype development. Furthermore, we noted lymphoid aggregates in K19-kras mice similar
to those found in H. felis-infected mice. While the antigen responsible for this adaptive immune
response is unknown, it is possible that mutant Kras peptides may induce the antigenic
response, as previously suggested (42,43) and contribute to phenotype development.
Additional inflammatory chemokines and growth factors, such as CXCL5, HB-EGF, and
Amphiregulin, were expressed relatively specific to the K19-kras mice compared to H. felis
dependent chronic gastritis. CXCL5 is an additional potent neutrophil chemoattractant (44),
linked to connective tissue remodeling, and has been associated with gastric cancer progression
independent of Helicobacter infection (45,46). Heparin-binding EGF-like growth factor (HB-
EGF) is expressed by both myeloid cells (47) and gastric cancer cells (48), and has been shown
to play a role in wound healing and carcinogenesis. Amphiregulin is also a member of the EGF
family that is expressed by epithelial cells and fibroblasts (49) and induced in tumor cells with
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Ras mutations (50). Given the link between these growth factors and EGF receptor signaling,
it seems likely that they contribute to the glandular proliferation and metaplasia phenotype in
the K19-kras mice.
One of the consequences of K-ras-induced chronic inflammation was the recruitment of
BMDCs to the stromal microenvironment in gastric dysplasia. Many of the BMDCs in BMT
recipient K19-kras mice were infiltrating immune cells, consistent with a previous observations
of lymphocyte infiltration in the pancreatic periduct and gastric mucosa of K19-kras mice
(13). However, BMDCs in the K19-kras mouse also comprised fibroblasts and myofibroblasts
(also known as Cancer-Associated Fibroblasts, or CAFs) that expressed vimentin ± α-SMA,
that surrounded the base of the dysplastic gastric glands. Stromal myofibroblasts are believed
to contribute to the stem cell niche in the gastrointestinal tract (51,52), but as yet the effects of
depleting these stromal cell populations is unknown. Previous studies have reported that many
CAFs present in tumors are likely to be bone marrow derived (53), and evidence for the
importance of a bone marrow contribution to tumor stroma has previously been recognized
(54). Thus, this is the first study to demonstrate that K-ras mutation on its own can lead to the
recruitment of BM-derived CAFs. Few epithelial cells were bone marrow-derived, in contrast
to earlier reports in the H. felis murine model (3).
Interestingly, in the K19-kras mouse stomach, there was a gradual expansion of Dcamkl1+
cells that moved down to the base of the gastric glands and clustered in a region adjacent to
BM-derived myofibroblastic niche cells, similar to that observed in the intestinal crypts of
APC/Min mice (20). Dcamkl1-expressing cells have been proposed as a candidate progenitor
cell fraction in both the stomach and intestine (19,20), raising the possibility that K-ras
overexpression in K19 cells may lead to an expansion of the gastric progenitor pool in the K19-
kras mouse. It is probable that the expansion of Dcamkl1+ cells was due to paracrine signals
from stromal cells and/or adjacent K19+ putative progenitors, rather than a direct effect of K-
ras within Dcamkl1+ cells, given that K19 and Dcamkl1 were differentially expressed in most
dysplastic cells. However, to date the only reported marker to lineage trace an entire gastric
gland is Lgr5 (25). Since LGr5 lineage tracing is restricted to the antrum and dysplasia in K19-
kras mice is found in the corpus, it is unlikely that Lgr5-derived cells are the primary source
of the corpus dysplasia. However, definitive data as to the source of dysplastic lesions will
require additional lineage tracing studies.
In conclusion, K-ras mutation in K19+ putative gastric tissue progenitor cells induced pro-
inflammatory responses, resulting in early onset of gastric dysplasia. Dcamkl1+ cells were
found clustered in dysplastic glands, adjacent to expanded K19+ regions. BMDCs contributed
significantly to the microenvironment of dysplastic glands as immune cells, fibroblasts, and
myofibroblasts. Further characterization of the relationship between K19+ and Dcamkl1+ cells
in the normal gastric epithelium and dysplastic lesions may provide greater insight into the
cellular and molecular mechanisms of carcinogenesis.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Gastric histology of WT and K19-kras mice
A-C. From mice 12 month cohort: body and stomach weights (A), representative gross
presentation (B), and H&E- and alcian blue-stained gastric tissue sections (C). Representative
Alcian blue+ cells in WT H. felis infected mice indicated by arrows, magnified insets are of
boxed regions (original magnification 100 and 150x, respectively). D. Histopathology scores
for gastric lesions of the mice at 3, 6, 12 months after H. felis infection (*p<0.01n=3 for each
group).
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Figure 2. Expression of chemokines/cytokines/growth factors
A, B, D. Quantitative real-time RT-PCR analysis of 12 month cohort (*p<0.1, §p<0.05, n>3
in each group)
C. Relationship between dysplasia score and mRNA expression of CXCL1 and IL-6 in K19-
kras mice at 12 months.
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Figure 3. Immunohistochemical staining in gastric epithelium of uninfected wild type and K19-
kras mice at 12 months
Expression of K19 (A, E), H/K ATPase (B, F), Ki67 (C, G), and Dcamkl1 (D, H) in the gastric
epithelium of WT (A-D) and K19-kras (E-H) mice (arrows indicate Dcamkl1+ cells, original
magnification 150x).
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Figure 4. Aged K19-kras mice develop high-grade dysplasia
A. Histopathology scores for dysplasia in gastric lesions of mice between 16 and 19 months
B. Gross presentation of the stomachs with papillary tumors. Stomachs from a WT mouse 19
months with H. felis infection (7445) and K19-kras mice at 16 to 19 months (9003 and 7456,
respectively).
C. H&E-stained gastric tissue section of a K19-kras mouse at 16 months displaying submucosal
penetration of intramucosal carcinoma (original magnification 200x)
D. Expression of Dcamkl1, K19, Ki67, and TFF2 in low- and high-grade dysplasia of a K19-
kras mouse (original magnification 300x).
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Figure 5. Detection of BMDCs in the gastric epithelium of recipient mice
Endogenous GFP fluorescence of BMDCs in gastric tissue of WT (A) or K19-kras (B) BMT
recipients (original magnification, 150x), quantified in (C) (*p<0.01, n=3 per group).
D. Representative E-cadherin (red) and GFP (green) in gastric tissue of K19-kras BMT
recipients. (original magnification, 200x). Magnified inset of a representative double positive
cell (bone marrow-derived epithelial cell) and GFP single positive cells (bone marrow-derived
stromal cells) are shown.
E. Representative immunohistochemistry for GFP in K19-kras BMT recipients detected by
(original magnification, 200x).
F. Y-FISH (red) in a gastric tissue section of a K19-kras female receiving male donor BMT
(original magnification, 400x).
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Figure 6. Characterization of BMDCs in BMT recipient mice
Gastric tissue sections from K19-kras BMT recipients detecting (A) endogenous GFP of
BMDCs, and stained red for CD45 (left), vimentin (middle), and (B) αSMA (right,), and
endogenous GFP (left, from a BMT recipient), or stained for F4/80 (middle, green) or αSMA
(right, green) and stained for Dcamkl1 (red, original magnification, 400x)
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